Evidence map›Paper›PMID 22012429›Full record

SynthesisGenes and immunity2012

The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.

J-E Martin, F D Carmona, J C A Broen, C P Simeón, M C Vonk, P Carreira, R Ríos-Fernández, G Espinosa, E Vicente-Rabaneda, C Tolosa and 33 more

Open access · bronzeAbstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Genes and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The Immunogenetics of Systemic Sclerosis.Advances in experimental medicine and biology · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Genetics of systemic sclerosis: recent advances.Current opinion in rheumatology · 2015
    Review
  9. Genetics, Epigenetics, and Genomics of Systemic Sclerosis.Rheumatic diseases clinics of North America · 2015
    Review
  10. Review
  11. Pathogenesis of Systemic Sclerosis.Frontiers in immunology · 2015
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 7 countries.

J-E MartinInstituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
F D Carmona
J C A Broen
C P Simeón
M C Vonk
P Carreira
R Ríos-Fernández
G Espinosa
E Vicente-Rabaneda
C Tolosa
F J García-Hernández
I Castellví
V Fonollosa
M A González-Gay
L Sáez-Comet
R García Portales
P García de la Peña
M Fernández-Castro
B Díaz
L Martínez-Estupiñán
M Coenen
A E Voskuyl
A J Schuerwegh
M Vanthuyne
F Houssiau
V Smith
F de Keyser
E De Langhe
G Riemekasten
T Witte
N Hunzelmann
A Kreuter
Ø Palm
M M Chee
J M van Laar
C Denton
A Herrick
J Worthington
B P C Koeleman
T R D J Radstake
C Fonseca
J Martín
Spanish Scleroderma Group
Radboud University Nijmegen · NLInstituto de Parasitología y Biomedicina "López - Neyra" · ESCliniques Universitaires Saint-Luc · BEHospital Virgen del Valle · ESManchester Academic Health Science Centre · GBThe Royal Free Hospital · GBCenter for Rheumatology · USCharité - Universitätsmedizin Berlin · DEDeleted InstitutionFundación Marques de Valdecilla · ESGlasgow Royal Infirmary · GBHospital Clínic de Barcelona · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Central de Asturias · ESHospital Universitario de La Princesa · ESHospital Universitario HM Sanchinarro · ESHospital Universitario Miguel Servet · ESHospital Universitario Puerta de Hierro Majadahonda · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory T cells (T(regs)) are crucial in the maintenance of the immune tolerance and seem to have an important role in systemic sclerosis (SSc). The interleukin 2 receptor α (IL2RA) is an important T(reg) marker, and polymorphisms of IL2RA gene are associated with a number of autoimmune diseases. Therefore, we aimed to investigate for the first time the association of the IL2RA locus in SSc. For this purpose, a total of 3023 SSc patients and 2735 matched healthy controls, from six European Caucasian cohorts, were genotyped for the IL2RA gene variants rs11594656, rs2104286 and rs12722495 using the TaqMan allelic discrimination technology. The overall meta-analysis reached statistical significance when the three polymorphisms were tested for association with SSc, the limited subtype (lcSSc) and anti-centromere auto-antibodies (ACAs). However, no significant P-values were obtained when the ACA-positive patients were removed from the SSc and lcSSc groups, suggesting that these associations rely on ACA positivity. The strongest association signal with ACA production was detected for rs2104286 (P(FDR)=2.07 × 10(-4), odds ratio=1.30 (1.14-1.47)). The associations of rs11594656 and rs12722495 were lost after conditioning to rs2104286, and allelic combination tests did not evidence a combined effect, indicating that rs2104286 best described the association between IL2RA and ACA presence in SSc.

Indexed as

AdultAutoimmune DiseasesGenetic LociHumansInterleukin-2 Receptor alpha SubunitMiddle AgedPolymorphism, Single NucleotideScleroderma, SystemicIL2RA protein, humanInterleukin-2 Receptor alpha Subunit

Identifiers

PMID22012429
OpenAlexW2098958311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.